Molecular mechanisms of cognitive impairment associated with stroke

M Kaur, S Sharma - Metabolic brain disease, 2022 - Springer
Stroke is the second leading cause of death after coronary heart disease in developed
countries and is the greatest cause of disability and cognitive impairment. Risk factors for …

Turning the spotlight to cholinergic pharmacotherapy of the human language system

G Dávila, MJ Torres-Prioris, D López-Barroso… - CNS drugs, 2023 - Springer
Even though language is essential in human communication, research on pharmacological
therapies for language deficits in highly prevalent neurodegenerative and vascular brain …

Ten key reasons for continuing research on pharmacotherapy for post-stroke aphasia

ML Berthier - Aphasiology, 2021 - Taylor & Francis
Background: Aphasia is a devastating disorder occurring in more than 30% of stroke victims.
Speech and language therapy (SLT) is the treatment of choice for post-stroke aphasia (PSA) …

Are pharmacotherapeutics effective for treating aphasia?

G Dávila, ML Berthier - Expert Review of Neurotherapeutics, 2024 - Taylor & Francis
Introduction Aphasia is a communication disorder resulting from stroke and/or
neurodegenerative conditions which involve the left cerebral hemisphere. It is a debilitating …

Pharmacotherapy for post-stroke aphasia: what are the options?

ML Berthier, G Dávila - Expert Opinion on Pharmacotherapy, 2023 - Taylor & Francis
Introduction Aphasia is a common, long-lasting aftermath of stroke lesions. There is an
increased integration of pharmacotherapy as an adjunctive strategy to speech and language …

Turning the spotlight to cholinergic pharmacotherapy of the human language system

MG Dávila-Arias, MJ Torres-Prioris, D López-Barroso… - 2023 - riuma.uma.es
Even though language is essential in human communication, research on pharmacological
therapies for language deficits in highly prevalent neurodegenerative and vascular brain …